Ubs Group Ag Sensei Biotherapeutics, Inc. Transaction History

Ubs Group Ag

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.73 - $1.17 $101 - $162	139 New	139 $0
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.81 $3,500 - $5,558	3,071 Added 89.27%	6,511 $7,000
Q1 2023 May 12, 2023	BUY	$1.31 - $1.7 $3,069 - $3,983	2,343 Added 213.58%	3,440 $5,000
Q4 2022 Feb 08, 2023	SELL	$1.33 - $1.74 $15,982 - $20,909	-12,017 Reduced 91.63%	1,097 $1,000
Q3 2022 Nov 10, 2022	SELL	$1.55 - $2.24 $540 - $781	-349 Reduced 2.59%	13,114 $20,000
Q2 2022 Aug 10, 2022	SELL	$1.49 - $2.3 $230 - $356	-155 Reduced 1.14%	13,463 $31,000
Q1 2022 May 16, 2022	SELL	$2.22 - $6.07 $19,500 - $53,318	-8,784 Reduced 39.21%	13,618 $31,000
Q4 2021 Feb 14, 2022	BUY	$4.85 - $10.48 $103,756 - $224,198	21,393 Added 2120.22%	22,402 $130,000
Q3 2021 Nov 15, 2021	BUY	$6.89 - $11.99 $2,170 - $3,776	315 Added 45.39%	1,009 $11,000
Q2 2021 Aug 13, 2021	SELL	$9.1 - $15.14 $12,785 - $21,271	-1,405 Reduced 66.94%	694 $7,000
Q1 2021 May 12, 2021	BUY	$12.04 - $22.75 $25,271 - $47,752	2,099 New	2,099 $31,000

2.23M

Ticker SNSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,720,300
Market Cap $15.4M
Description
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.